Urinary hemosiderin: role in evaluation of chronic venous insufficiency

Chronic venous insufficiency (CVI) leads to skin changes with dermal hemosiderin deposition. We studied the presence of hemosiderin in the urine to assess if this could be used as a biochemical marker for CVI. Hereby we present a case control study conducted in a tertiary care centre in South India. There were 100 cases with evidence of advanced CVI (the Clinical-Etiology-Anatomy-Pathophysiology classification: C5, C6) confirmed by duplex scanning. Controls were 50 patients with leg ulcers due to other etiologies. All patients were subjected to urinary hemosiderin testing. In all 100 patients with CVI (C5 and C6 disease) axial venous reflux was confirmed by duplex ultrasound. Superficial venous reflux was noted in 71% of patients and deep venous reflux in 54.%. Primary venous insufficiency was the etiology in 81% of patients. Only 4/100 patients had detectable amounts of hemosiderin in the urine. Urine hemosiderin testing to determine presence or absence of CVI yielded the following values: positive predictive value-80%; negative predictive value-33%; sensitivity-4% and specificity-98%. The test could not be recommended as a marker of CVI. In Indian patients urinary hemosiderin is not a useful screening test in CVI.

[1]  G. Choudhuri,et al.  Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population , 2011, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[2]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[3]  P. Zamboni,et al.  Skin iron deposition characterises lipodermatosclerosis and leg ulcer. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  D. Gemmati,et al.  DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. , 2009, Journal of vascular surgery.

[5]  Z. Rybak,et al.  Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. , 2008, Medical hypotheses.

[6]  K. Burnand,et al.  Tissue and urinary haemosiderin in chronic leg ulcers. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[7]  Y. Chawla,et al.  Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. , 2007, World journal of gastroenterology.

[8]  S. Tognazzo,et al.  Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. , 2006, Journal of vascular surgery.

[9]  S. Tognazzo,et al.  The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. , 2006, Free radical biology & medicine.

[10]  S. Tognazzo,et al.  Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. , 2006, Journal of vascular surgery.

[11]  S. Tognazzo,et al.  Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. , 2005, Journal of vascular surgery.

[12]  P. Zamboni,et al.  Urine hemosiderin: a novel marker to assess the severity of chronic venous disease. , 2003, Journal of vascular surgery.

[13]  I. de Vincenzi,et al.  Importance of the familial factor in varicose disease. Clinical study of 134 families. , 1994, The Journal of dermatologic surgery and oncology.

[14]  S. Malhotra.  An epidemiological study of varicose veins in Indian railroad workers from the South and North of India, with special reference to the causation and prevention of varicose veins. , 1972, International journal of epidemiology.